Specifically, high ASH1L-AS1 expression is associated with decreased infiltration of cytotoxic CD8+T cells and macrophages, and enrichment of non-cytotoxic T cell subsets, indicative of an immunologically “cold” tumor phenotype (Fig. S1E). The gene discussed is CD8A; the disease is neoplasm.